STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Indivior Announces Q1 2025 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Indivior (Nasdaq/LSE: INDV) has announced the release of its Q1 2025 financial results for the period ending March 31, 2025. The company has made available its earnings release and investor presentation on their corporate website www.indivior.com.

A live webcast presentation is scheduled for 13:00 BST (8:00 am ET), to be hosted by CEO Mark Crossley. Participants can access the presentation through a webcast link or join telephonically by registering through the provided registration link.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SLOUGH, United Kingdom and RICHMOND, Va., April 24, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending March 31, 2025. The earnings release, investor presentation and webcast are available at www.indivior.com.

There will be a live webcast presentation at 13:00 BST (8:00 am ET) hosted by Mark Crossley, CEO. The details are below.

Webcast link: https://edge.media-server.com/mmc/p/yn37cxqk 
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BI4482694d7c294502b6a4dedd62e88c5b
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration) 

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q1-2025-financial-results-302434707.html

SOURCE Indivior PLC

FAQ

When will Indivior (INDV) report its Q1 2025 earnings?

Indivior will host its Q1 2025 earnings presentation on April 24, 2025, at 13:00 BST (8:00 am ET).

How can investors access Indivior's (INDV) Q1 2025 earnings presentation?

Investors can access the presentation via webcast at edge.media-server.com or register for the telephone conference through the provided registration link.

Where can I find Indivior's (INDV) Q1 2025 earnings release and investor presentation?

The earnings release and investor presentation are available at www.indivior.com/investors.

Who will present Indivior's (INDV) Q1 2025 financial results?

CEO Mark Crossley will host the Q1 2025 earnings presentation.
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

4.19B
120.03M
3.88%
88.1%
6.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE